跳至主要内容
临床试验/CTRI/2026/01/101068
CTRI/2026/01/101068招募中2/3 期

Randomized Controlled Clinical Study To Evaluate Add-On Effect of Polyherbal Ayurvedic Formulation (Cap.BPSolve) With Tab. Telmisartan In the Management Of Essential Hypertension

Amruta Chandrakant Pacharne1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2026年1月31日最近更新:

试验速览

阶段
2/3 期
状态
招募中
发起方
入组人数
160
试验地点
1

研究概览

简要总结

This Study is a Randomised open labelled controlled clinical trial to compare the efficacy and add on effect of 6 herbal  Ayurvedic drug Formulation Cap BPSolve with Tab Telmisartan.

This study is  for 15 days in 160 Patients divided into 2 groups with Essential Hypertension and the effect on Systolic blood pressure ,Diastolic blood pressure, Heart-rate and other parameters like Headache, Fatigue ,Palpitation ,Insomnia , Giddiness etc

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Systolic Blood Pressure: less than 170 mm of Hg more than or equal to 140 mm of Hg. Diastolic Blood Pressure: less than or equal to 110 mm of Hg More than 90 mm of Hg. Patient willing to participate in the research & to sign the written informed consent form.

排除标准

  • Patient who has past history of atrial fibrillation, acute coronam syndrome, myocardial infarction, stroke or right ventricular hypertrophy, left ventricular hypertrophy, severe arrhythmia months.
  • Symptomatic patients with clinical features of early heart fai Secondary hypertension.
  • Women who are pregnant and lactating or on estrogen rep therapy.
  • Alcoholics and drug abusers.
  • Accelerated and malignant hypertension.

研究者

发起方
Amruta Chandrakant Pacharne
申办方类型
Other [Self ]
责任方
Principal Investigator
主要研究者

Amruta Chandrakant Pacharne

Siddhakala Ayurveda Mahavidyalaya , Sangmaner

研究点 (1)

Loading locations...

相似试验